EGF and triple-negative breast carcinoma: Mechanistically, PTPN11 enhances the oncogenic activity of β-catenin and activates Src family kinases, as well as regulates focal adhesion kinase (FAK) to promote epidermal growth factor (EGF)-induced lamellipodia persistence and migration of triple-negative breast cancer (TNBC) cells (25–27).